Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea

European Respiratory Journal

Volumn 39, Issue 1, 2012, Pages 215-217

  Almendros, I ^a   Montserrat, J M ^a,b   Ramirez J ^b   Torres, M ^a   Duran Cantolla, J ^a,e   Navajas, D ^a,c,d   Farre R ^a,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APNEA HYPOPNEA INDEX; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CIRCULATION; CONTROLLED STUDY; DISEASE ACTIVITY; HYPOXIA; LETTER; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLEEP APNEA SYNDROME; TISSUE OXYGENATION; TUMOR NECROSIS; TUMOR VOLUME;

ANIMALS; ANOXIA; CELL LINE, TUMOR; COMORBIDITY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS; SLEEP APNEA SYNDROMES; TREATMENT OUTCOME;

EID: 84855388054     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00185110     Document Type: Letter

References (10)

1. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-490. (Pubitemid 28373960)
2. Madi L, Bar-Yehuda S, Barer F, et al. A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition. J Biol Chem 2003; 278: 42121-42130. (Pubitemid 37310479)
3. Rofstad EK, Gaustad JV, Egeland TAM, et al. Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination. Int J Cancer 2010; 127: 1535-1546.
4. Cormier SA, Taranova AG, Bedient C, et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 2006; 79: 1131-1139. (Pubitemid 44835546)
5. Terraneo L, Bianciardi P, Caretti A, et al. Chronic systemic hypoxia promotes LNCaP prostate cancer growth in vivo. Prostate 2010; 70: 1243-1254.
6. Yao K, Gietema JA, Shida S, et al. In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo. Br J Cancer 2005; 93: 1356-1363. (Pubitemid 41752862)
7. Toffoli S, Michiels C. Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J 2008; 275: 2991-3002. (Pubitemid 351743577)
8. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47. (Pubitemid 37328806)
9. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist 2004; 9: 10-17. (Pubitemid 39658341)
10. Bachmann IM, Ladstein RG, Straume O, et al. Tumor necrosis is associated with increased avb3 integrin expression and poor prognosis in nodular cutaneous melanomas. BMC Cancer 2008; 8: 362.